Aim-To evaluate whether increased telomerase activity can be clinically useful for detecting malignant cells in a variety of gynaecological specimens. Methods-Telomerase activity was examined in frozen tissue samples of histologically confirmed lesions of the endometrium, ovary, and cervix. It was also assessed in exfoliated cells in cervical smears from patients with premalignant and malignant lesions and in ascitic fluid obtained from cases with malignant or non-malignant ovarian tumours. Results-Solid tissues from carcinomas were telomerase positive in all specimens of endometrial (616) and cervical (6/6) origin, and in almost all from the ovary (12/13). Normal tissues from the cervix (0I5) and the ovary (015) were telomerase negative, but samples from normal endometrium were found to show telomerase activity, possibly due to the cyclical regenerative nature of this tissue. Conversely, dissociated cells in cervical smears from preneoplastic and frankly neoplastic lesions rarely showed detectable telomerase activity. Thus smears from patients with malignant tumours were only positive in one of two patients, whereas those from CIN-2 (0/5) and CIN-3 (1117) lesions and from normal (0110) samples were almost all negative. Telomerase activity was also scarcely detectable in cells obtained from ascitic fluid from patients with ovarian tumours. Conclusions-As in many other organs, telomerase activity is increased in solid tissue specimens from malignant tumours of the female reproductive tract, but it is not yet a reliable indicator of the presence of exfoliated cancerous or precancerous cells in clinical specimens from such lesions. Interpretation should be guarded until more extensive studies have been conducted. The data on solid tissues presented here confirm that activation of this enzyme is a major hallmark of the neoplastic process. (i Clin Pathol 1997;50:501-504) 
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(i Clin Pathol 1997;50:501-504) Keywords : telomerase activity; gynaecological carcinoma; early diagnosis Telomeres are specialised nucleoprotein structures at the ends of eukaryotic chromosomes in which the DNA is composed of several hundred repeats of a simple hexanucleotide sequence (TTAGGG) extending up to 30 kb.' These telomeric regions play an important role in the structural integrity and function of chromosomes because they anchor the terminal regions to the nuclear membrane and protect them from untimely recombination events. The telomeres are believed to act as a buffer zone which allows for the loss of terminal DNA that occurs each time a chromosome is replicated without disruption of vital protein coding sequences. Replication related shortening of telomeric DNA to a critical length has been implicated as a signal for cells to stop dividing and to enter a senescent state. As a result of this "end-replication" problem, somatic cells have a limited proliferative capacity. Maintenance of telomere length is therefore considered to be necessary for continued cell division and immortalisation.A This can be achieved in vivo by the activation of telomerase, a ribonucleoprotein RNA dependent DNA polymerase that adds telomeric hexanucleotide repeats to the ends of replicating chromosomes.56
Recent investigations have shown that telomerase activity is demonstrable in the vast majority of human cancer cell lines and tumours tested, but it is absent or present at very low levels in somatic cells.7 The "telomeric repeat amplification protocol"8 (TRAP assay) is extremely sensitive and has been used to detect the presence of telomerase activity in carcinomas from a number of organs including the lung,9 gastrointestinal tract,'10' and bladder.'2 However, to date few studies have been undertaken to assess the value of the TRAP assay in the detection of carcinoma in samples from the female reproductive tract (endometrium, ovary, and cervix). Cervical smears were obtained with informed consent from five patients with cervical intraepithelial neoplasia (CIN) II, 17 with CIN III, two with carcinomas (one microinvasive, one invasive), and 10 with no detectable lesion. The samples used consisted of the redundant cellular material on the spatulae after preparation of cytological smears for diagnostic purposes. The cells were resuspended in phosphate buffered saline, centrifuged, and stored as above.
Methods

PROTEIN EXTRACTION AND TELOMERASE ASSAYS
Protein extractions were performed according to protocols published previously.8 Briefly, cell pellets or 20 cryostat sections 10 gm thick from tissue samples were resuspended in TRAP lysis buffer, incubated on ice, and centrifuged. The resulting supernatant was snap frozen in liquid nitrogen and stored at -70°C. Six micrograms of protein extract were used for each telomerase assay. Telomerase activity was detected by the TRAP assay.8 This detects the presence of telomerase activity by its ability to extend a synthetic oligonucleotide substrate which is added to the reaction mixture. The enzyme can act processively, so many extended DNA molecules of different lengths are produced. These are then amplified by polymerase chain reaction (PCR) using specific primers and the products are visualised as a ladder pattern of bands at six base pair intervals. RNase sensitivity of the TRAP assay was assessed by digesting 10 jl of the cell extract (10 jig protein) with 0.5 jg of RNase A (Boehringer Mannheim, Germany) for 20 minutes at 37°C, and 6 jg of the protein extract were used in the TRAP assay. To reveal the possible presence of PCR inhibitors, extracts were further diluted to 0.6 jig of protein per assay. Enzyme activity correlated well with the presence of cancer in solid cervical tissue specimens and was not detectable in normal controls, but it was seen in only one of 22 smears from premalignant CIN II and CIN III lesions. Hence it would appear to be of limited practical value for the detection of early non-invasive lesions, but further studies on cervical epithelia from the transition zone could be valuable for the identification of the precise stage at which telomerase is activated during the multistage development of cancers. Telomerase activity has been detected in exfoliated cells in urine from a significant proportion of bladder cancer patients,'2 in washings from colectomy specimens containing carcinomas,20 and in fine needle aspirates of breast carcinomas.2' Therefore, as the assay is sensitive enough to detect small numbers of cancer cells, it may be that the preneoplastic epithelial cells in CIN lesions
have not yet reached the threshold of chromosomal instability at which increased telomerase activity is triggered.
As in the case of cervical cancer, fresh tissue specimens of ovarian cancer all showed strong telomerase activity, but it was not detectable in any of our samples of non-neoplastic ovarian tissue. In the investigation of patients with suspected ovarian carcinomas it would be of great practical advantage to be able to establish a 
